Bone Biologics Corp - BBLG
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | History | New | 290,000 | 143 | 0.0% | — | 1 | +290,000 | New | Q3 2026 | Nov 16, 2026 |
| HRT FINANCIAL LP | History | New | 67,963 | 33 | 0.0% | — | 2 | +67,963 | New | Q3 2026 | Nov 13, 2026 |
| CITADEL ADVISORS LLC | History | Added to | 42,126 | 20 | 0.0% | 0.0% | 3 | +18,247 | 76.41% | Q3 2026 | Nov 16, 2026 |
| Virtu Financial LLC | History | New | 20,694 | 10 | 0.0% | — | 4 | +20,694 | New | Q3 2026 | Nov 17, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | History | New | 11,970 | 5 | 0.0% | — | 5 | +11,970 | New | Q3 2026 | Nov 16, 2026 |
| Tower Research Capital LLC (TRC) | History | Added to | 2,244 | 1 | 0.0% | 0.0% | 6 | +291 | 14.9% | Q3 2026 | Nov 16, 2026 |
| SBI Securities Co., Ltd. | History | Added to | 341 | 0 | — | — | — | +111 | 48.26% | Q3 2026 | Oct 21, 2026 |
| Caitong International Asset Management Co., Ltd | History | New | 1 | 0 | — | — | — | +1 | New | Q3 2026 | Oct 29, 2026 |